
In pooled CORALreef data, patients with eGFR below 60 had a 65.9% placebo-adjusted LDL-C reduction at week 24, with safety comparable to placebo.
Christopher Betz, PharmD, BCPS, FKSHP, FASHP, discusses the investigations that preceded the ACC/AHA Updated Heart Failure Guidelines
Christopher Betz, PharmD, BCPS, FKSHP, FASHP, discusses the investigations that preceded the ACC/AHA Updated Heart Failure Guidelines






